Archer Daniels Midland
ADM
$80.61
+0.29%
Archer-Daniels-Midland Company (ADM) is a global leader in agricultural processing and commodity merchandising, operating across oilseeds, corn, wheat, and other crops, with a growing nutrition business. As one of the world's largest grain handlers and a key producer of sweeteners, starches, and ethanol, ADM holds a dominant position in the agricultural supply chain. The current investor narrative centers on the company's recovery from a challenging period of margin compression in its core Ag Services segment, with recent quarters showing improving profitability and a strong stock rally driven by better-than-expected earnings and strategic cost actions. Debate remains around the sustainability of the turnaround, given volatile commodity markets and regulatory scrutiny.…
ADM
Archer Daniels Midland
$80.61
Investment Opinion: Should I buy ADM Today?
Rating: Hold. ADM is a cyclical commodity processor with improving earnings but a stock price that has already priced in much of the recovery. The consensus analyst rating is 'hold' with an average target of $75.30, implying 12.4% downside from the current price of $85.92. Supporting Evidence: The forward P/E of 15.7x is below the 5-year average of 17x, suggesting reasonable valuation if earnings meet estimates. Revenue growth is modest at 1.6% YoY, but net income has rebounded strongly from $108M to $298M sequentially. Free cash flow over the TTM is $4.79B, supporting the 3.5% dividend yield. However, the payout ratio of 91.6% is a concern. Risks & Conditions: The biggest risks are margin compression (gross margin 5.96%) and the high payout ratio. This Hold would upgrade to Buy if the forward P/E compresses below 12x or if revenue growth accelerates above 5%. It would downgrade to Sell if gross margins fall below 5% or if the dividend is cut. Overall, ADM appears fairly valued relative to its history but overvalued relative to analyst targets.
Sign up to view all
ADM 12-Month Price Forecast
ADM's outlook is balanced: the earnings recovery is real but the stock has already rallied 54.8% in the past year, leaving limited upside. The base case of a pullback toward $75 is most likely given the analyst consensus. A bullish stance would require evidence of sustained margin expansion, while a bearish stance would be triggered by a reversal in earnings. The neutral stance reflects the tug-of-war between improving fundamentals and stretched valuation.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Archer Daniels Midland's 12-month outlook, with a consensus price target around $75.50 and implied upside of -6.3% versus the current price.
Average Target
$75.50
0 analysts
Implied Upside
-6.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$60 - $95
Analyst target range
ADM is covered by 10 analysts, with a consensus recommendation of 'hold' and an average target price of $75.30. This implies a downside of 12.4% from the current price of $85.92, indicating that analysts believe the stock is overvalued at current levels. The distribution of ratings shows a mix of views: UBS maintains a Buy, while JP Morgan and Morgan Stanley rate it Underweight, and Barclays and Jefferies are at Equal Weight/Hold. The consensus leans neutral-to-bearish, with the average target well below the current price. The target price range spans from a low of $60.00 to a high of $95.00, representing a wide spread of $35.00, which signals high uncertainty about ADM's future. The high target of $95.00 assumes a successful turnaround with margin expansion and growth in the Nutrition segment, while the low target of $60.00 prices in continued margin compression and potential headwinds from commodity price declines. Recent ratings actions show no major changes, with UBS reiterating Buy in June 2026 and JP Morgan and Morgan Stanley maintaining Underweight since early 2026. The wide dispersion in targets and the hold consensus suggest that the stock's recent rally has outpaced fundamental improvements, and investors should be cautious about chasing the momentum.
Bulls vs Bears: ADM Investment Factors
ADM presents a mixed picture: the bull case rests on a strong earnings recovery from the 2024 trough, a solid balance sheet, and a forward P/E that appears reasonable if earnings continue to improve. The bear case highlights that the stock has rallied 54.8% in the past year, now trading above the average analyst target of $75.30, with thin margins and stagnant revenue growth. The most important tension is whether the earnings recovery is sustainable—if margins expand further, the forward P/E of 15.7x could prove cheap; if commodity headwinds return, the stock could fall back toward the low target of $60. Currently, the evidence slightly favors the bears given the valuation disconnect with analyst targets.
Bullish
- Strong Earnings Recovery Momentum: Net income improved from $108 million in Q3 2025 to $298 million in Q1 2026, a 176% sequential increase. EPS rose from $0.22 to $0.62, signaling a clear turnaround from the trough.
- Solid Balance Sheet and Liquidity: Debt-to-equity is only 0.37 and the current ratio is 11.2, indicating very low financial risk. Free cash flow over the trailing twelve months is $4.79 billion, providing ample capacity for dividends and investments.
- Attractive Forward Valuation: The forward P/E of 15.7x is below the 5-year average of ~17x and in line with industry peers. This suggests the stock is reasonably priced if earnings recovery materializes as expected.
- Strong Price Momentum and Relative Strength: ADM is up 54.8% over the past year, vastly outperforming the S&P 500's 16.5% gain. The 1-month relative strength of 13.7% confirms strong stock-specific catalysts driving the rally.
Bearish
- Analyst Consensus Hold with Downside: The average analyst target is $75.30, implying 12.4% downside from the current price of $85.92. The consensus rating is 'hold', with several major banks rating it Underweight.
- Thin and Volatile Margins: Gross margin in Q1 2026 was only 5.96%, down from 6.34% in Q4 2025 and well below 8.6% in Q1 2023. Operating margin of 1.99% is typical for commodities but leaves little room for error.
- Stagnant Top-Line Growth: Revenue grew only 1.6% YoY in Q1 2026 to $20.49 billion, and has fluctuated between $18.56B and $21.49B over the past four quarters. The lack of volume growth makes earnings dependent on commodity price cycles.
- High Payout Ratio Limits Dividend Growth: The dividend yield is attractive at 3.5%, but the payout ratio of 91.6% leaves minimal room for increases. Any earnings disappointment could force a dividend cut.
ADM Technical Analysis
ADM is in a sustained uptrend, with the stock up 54.8% over the past year, significantly outperforming the S&P 500's 16.5% gain. The current price of $85.92 sits at 97.1% of its 52-week range (low $52.96, high $88.46), indicating the stock is near its highs and reflecting strong momentum. This positioning suggests bullish sentiment but also raises caution about potential overextension, as the stock is trading just 2.9% below its 52-week high. Short-term momentum is accelerating sharply, with 1-month and 3-month price changes of +14.4% and +24.1%, respectively, both outpacing the S&P 500's gains of 0.8% and 3.5%. This divergence from the broader market signals strong stock-specific catalysts, likely tied to earnings improvements, and suggests the uptrend is intact with no signs of deceleration. The 1-month relative strength of 13.7% versus the S&P confirms ADM is a market leader. Key support lies at the 52-week low of $52.96, while resistance is at the 52-week high of $88.46. A breakout above $88.46 would signal a continuation of the uptrend and potentially open the door to further gains, while a breakdown below recent support near $76 (the June lows) could indicate a trend reversal. With a beta of 0.61, ADM is less volatile than the market, meaning its moves are more muted relative to the S&P 500, which is favorable for risk-averse investors but may limit upside in strong market rallies.
Beta
0.61
0.61x market volatility
Max Drawdown
-12.8%
Largest decline past year
52-Week Range
$53-$88
Price range past year
Annual Return
+46.0%
Cumulative gain past year
| Period | ADM Return | S&P 500 |
|---|---|---|
| 1m | +5.5% | -0.7% |
| 3m | +7.6% | +2.9% |
| 6m | +19.8% | +7.2% |
| 1y | +46.0% | +16.9% |
| ytd | +36.5% | +8.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ADM Fundamental Analysis
ADM's revenue trajectory shows modest growth, with Q1 2026 revenue of $20.49 billion, up 1.6% year-over-year, but below the $21.19 billion reported in Q2 2025. Over the trailing four quarters, revenue has fluctuated between $18.56 billion and $21.49 billion, indicating a stagnant top line. The Ag Services and Oilseeds segment, which generated $16.0 billion in Q1 2026, remains the primary revenue driver, while Carbohydrate Solutions ($2.56 billion) and Nutrition ($1.81 billion) contribute smaller but more stable streams. The lack of robust growth suggests ADM is reliant on commodity price cycles rather than volume expansion, which is a key risk for the investment case. Profitability has been under pressure, with Q1 2026 net income of $298 million and a gross margin of 5.96%, down from 6.34% in Q4 2025 and well below the 8.6% seen in Q1 2023. However, net income improved sequentially from $108 million in Q3 2025, and the net margin of 1.45% in Q1 2026 is up from 0.53% in Q3 2025, suggesting a gradual recovery. The operating margin of 1.99% remains thin, typical for the agricultural commodity industry, but the trend is stabilizing after hitting a low of 0.47% in Q2 2025. ADM's balance sheet is solid, with a debt-to-equity ratio of 0.37 and a current ratio of 11.2, indicating ample liquidity. Free cash flow over the trailing twelve months was $4.79 billion, though Q1 2026 saw negative free cash flow of -$44 million due to working capital swings. Return on equity (ROE) of 4.7% is low but improving from 0.8% in Q3 2024, reflecting the earnings recovery. The strong cash generation supports the dividend yield of 3.5%, but the payout ratio of 91.6% suggests limited room for increases.
Quarterly Revenue
$20.5B
2026-03
Revenue YoY Growth
+1.6%
YoY Comparison
Gross Margin
6.0%
Latest Quarter
Free Cash Flow
$4.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ADM Overvalued?
Since ADM has positive net income, the primary valuation metric is the P/E ratio. The trailing P/E stands at 25.8x, while the forward P/E is 15.7x, implying the market expects earnings to grow significantly in the coming year. This gap between trailing and forward multiples suggests that the current price already reflects anticipated earnings recovery, and any disappointment could lead to multiple contraction. Compared to the industry average P/E (not provided, but typically for agricultural commodities around 15-20x), ADM's trailing P/E of 25.8x appears elevated, but the forward P/E of 15.7x is more in line with peers. The P/S ratio of 0.35x is low, reflecting the thin margins of the commodity business. Historically, ADM's trailing P/E has ranged from 8.9x (Q2 2022) to 400x (Q3 2024), with the current 25.8x near the middle of that range. However, the forward P/E of 15.7x is below the 5-year average of around 17x, suggesting the stock is reasonably valued relative to its own history if earnings materialize as expected. The PEG ratio of -0.66 is negative due to negative earnings growth expectations, which is a red flag, but this may be distorted by the recent earnings trough.
PE
25.8x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 9x~20x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: ADM's thin gross margin of 5.96% and operating margin of 1.99% leave the company highly exposed to input cost inflation or commodity price declines. The payout ratio of 91.6% on the dividend is unsustainable if earnings dip again, and free cash flow turned negative in Q1 2026 at -$44 million due to working capital swings. Revenue growth is stagnant at 1.6% YoY, indicating reliance on commodity cycles rather than volume expansion. Market & Competitive Risks: The stock's trailing P/E of 25.8x is elevated relative to the forward P/E of 15.7x, implying the market is pricing in a sharp earnings recovery that may not materialize. With a beta of 0.61, ADM is less volatile than the market, but it is still sensitive to agricultural commodity prices and trade policy. The analyst consensus 'hold' and average target 12.4% below the current price suggest the stock is overvalued relative to fundamental estimates. Worst-Case Scenario: If commodity prices decline sharply or the earnings recovery stalls, ADM could fall to its 52-week low of $52.96, representing a 38.4% decline from the current price of $85.92. This scenario could be triggered by a global recession reducing demand for agricultural commodities or a severe drought impacting crop yields. The low analyst target of $60.00 implies a 30.2% downside, which is a more moderate bear case.
FAQ
The key risks are: 1) Margin compression – gross margin is only 5.96% and operating margin 1.99%, making earnings highly sensitive to commodity prices. 2) Dividend sustainability – the payout ratio of 91.6% leaves little room for error; a earnings miss could force a cut. 3) Valuation risk – the stock trades above the average analyst target of $75.30, implying a 12.4% downside. 4) Macro risk – with a beta of 0.61, ADM is less volatile than the market but still exposed to global economic cycles and trade policy. The most severe risk is a commodity downturn that could push the stock to the 52-week low of $52.96, a 38.4% decline.
The 12-month forecast is mixed. In the base case (50% probability), the stock pulls back to the analyst average target of $75.30, as the market digests the recent rally. In the bull case (25% probability), earnings momentum drives the stock to the high target of $95.00, a 10.6% upside. In the bear case (25% probability), a reversal in earnings sends the stock to the low target of $60.00 or the 52-week low of $52.96, representing a 30-38% decline. The most likely scenario is the base case, given the hold consensus and the stock's proximity to its 52-week high.
ADM appears fairly valued on a forward basis but overvalued relative to analyst targets. The forward P/E of 15.7x is below the 5-year average of 17x, suggesting reasonable valuation if earnings recover as expected. However, the trailing P/E of 25.8x is elevated, reflecting the recent earnings trough. The P/S ratio of 0.35x is low, typical for commodity processors. Compared to the industry average P/E (estimated 15-20x), ADM's forward multiple is in line. The market is pricing in an earnings recovery that may be optimistic, as indicated by the analyst average target 12.4% below the current price. Overall, the stock is not cheap but not excessively overvalued.
ADM is a hold rather than a buy at the current price of $85.92. The stock has strong momentum, up 54.8% over the past year, and a solid balance sheet with a debt-to-equity ratio of 0.37. However, the average analyst target of $75.30 implies 12.4% downside, and the consensus rating is 'hold'. The forward P/E of 15.7x is reasonable, but the trailing P/E of 25.8x suggests the market has already priced in a sharp earnings recovery. For income-focused investors, the 3.5% dividend yield is attractive, but the 91.6% payout ratio is a risk. A good buy would be at a price closer to the analyst average target, offering a better margin of safety.
ADM is better suited for long-term, income-oriented investors rather than short-term traders. The stock has a beta of 0.61, indicating lower volatility, and a dividend yield of 3.5%, providing a steady income stream. The earnings recovery story could play out over 12-24 months, but the stock's recent 54.8% rally suggests near-term upside is limited. Short-term traders may find the momentum attractive, but the risk of a pullback to the analyst target is high. A minimum holding period of 2-3 years is recommended to ride out commodity cycles and allow the Nutrition segment to contribute more meaningfully to earnings.